Trent W. Nichols Jr. MD, is an internist, nutritionist, and gastroenterologist with more than 30 years of clinical experience. He is the founder and director of the CNDD and the Advanced Magnetic Research Institute in Hanover, Pennsylvania. He is a graduate of the University of Denver with a BS in Chemistry and Northwestern University with a MD. His postgraduate education medicine was at Northwestern University in Internal Medicine and Fellowship in Gastroenterology and Hepatology. He has been the lead investigator in over 50 pharmaceutical trials and has worked for the Veterans Administration, Kaiser Permanente, Good Samaritan Hospital in Lebanon PA, and Sinai Hospital In Baltimore MD. He is a member of the American Gastroenterology Association, Society for Neuroscience, and Bioelectromagnetic Society. He is on the editorial panel for the Journal of Liver, OMICS and has been active researcher in the role of mitochondrial dysfunction in liver disease and therapy with EMF.

Fatty liver, Mitochondrial defect, Genetic preconditions to NASH and the “missing link” to chronic illness, Role of mitochondrial dysfunction in liver disease and therapy with EMF.

Chait completed his MD degree at the age of 25 from the University of California School of Medicine at San Francisco. Maxwell is a Fellow of several prestigious organizations, including the American College of Physicians, American College of Gastroenterology, American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy. He is a practicing gastroenterologist on the faculty of the Columbia University College of Physicians and Surgeons. Dr. Maxwell has authored more than 37 publications in reputed journals and serves on the editorial board of the World Journal of Gastrointestinal Endoscopy.

Gastroenterology and Gastrointestinal endoscopy.

Dr. David Van Thiel is a gastroenterologist in Berwyn, Illinois. He is affiliated with multiple hospitals in the area, including Rush Oak Park Hospital and Rush University Medical Center. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice for 39 years. Dr. Van Thiel accepts several types of health insurance, listed below. He is one of 21 doctors at Rush Oak Park Hospital and one of 25 at Rush University Medical Center who specialize in Gastroenterology. Dr. Van Thiel graduated from University of California at Los Angeles. Dr. David H Van Thiel, MD has obtained board certification from the member board for Internal Medicine and Hepatology.

Dr. David H Van Thiel, MD has expertise in 17 areas. This includes Cryoglobulinemia, Liver Diseases, Alcoholic Liver Cirrhosis plus others. Dr. David Van Thiel practices Internal Medicine, Hepatology, Gastroenterology near Chicago, IL.

Dr. Mark A. Feitelson attended Cypress College (Cypress, CA) from 1970-72, and then received a B.S. degree in biology from the University of California, Irvine in 1974. Advanced studies resulted in a Ph.D. in Microbiology and Immunology from the UCLA School of Medicine in 1979. He was then an American Cancer Society postdoctoral fellow in the Department of Medicine at Stanford University from 1980-1982, where he started his work with hepatitis B virus (HBV). Dr. Feitelson was then recruited to the Fox Chase Cancer Center by Dr. Baruch Blumberg (who won the Nobel Prize for his discovery of HBV) where he continued his work in HBV. In 1988, Dr. Feitelson became an independent faculty member at the Fox Chase Cancer Center at the rank of Associate Member. In 1991, Dr. Feitelson was recruited as an Associate Professor in the Department of Pathology, Anatomy and Cell Biology at Thomas Jefferson University, and from 1997-2007 has been a full-professor in the same department. He also held a secondary appointment in the Department of Microbiology and Immunology within the Kimmel Cancer Center at Jefferson. During this time, Dr. Feitelson ran a CAP certified clinical molecular diagnostic lab in microbiology for Thomas Jefferson University Hospital. Dr. Feitelson is presently Professor of Biology at Temple University and Associate Director of the Temple Biotechnology Center. Dr. Feitelson has over 100 publications in highly ranked international scientific journals, has written two books; delivered more than 160 oral presentations and/or posters at national and international scientific meetings, and has delivered more than 100 invited lectureships all over the world. Dr. Feitelson has recently been named outstanding alumnus of Cypress College.

Pathogenesis, Hepatitis B/C, Hepatocellular carcinoma.

Eve-Isabelle Pecheur has completed her PhD in 1997 from University Paris XI and postdoctoral studies from Groningen University of Medical Sciences, Netherland. She leads her research group at the Cancer Research Center of Lyon. She has published more than 50 papers in reputed journals. She is serving as an editorial board member of Antiviral Research, and as an academic editor of PLoS ONE.

Viral hepatitis and Hepatocellular carcinoma

Dr. Anil K. Kaul received a medical degree from Madras Medical College of Madras University, a dental degree from King Georges’ Medical College, both in India, and a master’s degree from the University of Minnesota School of Public Health. He completed a post-doctoral fellowship at the University of Texas in Galveston. He is the director of clinical laboratories and Associate professor of 'Obstetrics & Gynecology' at Oklahoma State University Center for Health Sciences. He also received the Science Achiever of the Year award at the South Asian Excellence Awards ceremony in New York City in 2008. He was nominated by the US Department of State for the “Expeditionary Service Award” for his assignment in Iraq. Secretary of State Hilary Clinton awarded the citation for committed service in extraordinary and arduous conditions during his field assignment in Iraq. He is the director of the Asia-Pacific region for the International Infectious Diseases Society for Obstetricians & Gynecologists. He holds several patents including one for early detection of premature births.

Kaul’s research focuses on infectious diseases with special interest in women’s health related issues including premature births. His current research involves developing new diagnostic tools for early detection of cancer, and osteoporosis, as well as wireless monitoring of pregnancy.

Eddie C. Cheung, M.D., FACG, is a Clinical Professor of Internal Medicine and Gastroenterology/Hepatology at the University of California at Davis, School of Medicine, as well as an Honorary Professor at the 302 Military Hospital in Beijing. He has been also on the Clinical Faculty at the Stanford University, School of Medicine and University of California at San Francisco, School of Medicine. He graduated from Taipei Medical University in 1974 and completed his Fellowship of Gastroenterology, Hepatology and Clinical Nutrition at the University of Louisville, Kentucky in 1980. He was the Director of Hepatology for the Veteran Administration Northern California Healthcare System in Martinez, California. He is the Hepatology Advisor for Vital Therapies (ELAD) in San Diego, California. He is the Director of Internal Medicine and Gastroenterology/Hepatology at the International Medical Center in Beijing, China and Asian Medical Clinic in Fremont, California. He also serves as the clinical investigator as well as on the Advisory Board and Speaker Bureau of the Chronic Liver Disease Foundation, Asian Health Foundation and various pharmaceutical companies. He founded the Asian Cancer Coalition and is on the Coalition to Eradicate Viral Hepatitis in Asia Pacific as well as the US National Task Force for Hepatitis B. He chaired the US/China Summit on Viral Hepatitis and Liver Cancer. He is the co-chair, moderator and on the International Advisory Board for Asia Pacific Association for the Study of the Liver Annual Meeting and Single Topic Conference. He is on the Executive Board of the California Hepatitis Alliance. He is on the Advisory Board of the Institute of Translational Hepatology. He received the Salute to Excellence Outstanding Community Service Award from the American Liver Foundation, Outstanding Contribution to Health Award from the Community Health Charities, the Distinguish Community Service Award from the Salvation Army and the Special Contribution Award from the Department of Veterans Affairs.

Prevention, diagnosis and treatment of esophagus, stomach, small intestine, colon, liver, pancreas, gall bladder and nutritional disorders.